Free Trial

CME Group Inc. (NASDAQ:CME) Shares Sold by Tritonpoint Wealth LLC

CME Group logo with Finance background

Tritonpoint Wealth LLC reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 4.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,905 shares of the financial services provider's stock after selling 1,080 shares during the quarter. Tritonpoint Wealth LLC's holdings in CME Group were worth $6,076,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CME. New Age Alpha Advisors LLC grew its holdings in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the last quarter. Knuff & Co LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $33,000. Banque Transatlantique SA purchased a new stake in shares of CME Group during the fourth quarter valued at $35,000. Whipplewood Advisors LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $37,000. Finally, United Community Bank purchased a new stake in shares of CME Group during the fourth quarter valued at $37,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CME shares. Bank of America boosted their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Barclays upped their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Morgan Stanley upped their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $258.20.

Get Our Latest Analysis on CME

CME Group Price Performance

Shares of CME Group stock traded down $1.46 during trading hours on Friday, reaching $269.50. The stock had a trading volume of 1,576,352 shares, compared to its average volume of 2,200,731. The stock's 50 day moving average is $272.73 and its 200 day moving average is $254.39. The firm has a market capitalization of $97.12 billion, a PE ratio of 27.87, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $290.79. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.50 earnings per share. Equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.86%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Insider Activity at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of the firm's stock in a transaction dated Thursday, April 24th. The shares were sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director now directly owns 38,651 shares of the company's stock, valued at approximately $10,207,729.10. This trade represents a 4.92% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the transaction, the insider now directly owns 8,336 shares in the company, valued at $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines